ICICI Securities Limited
Auxiliary income increased 21% YoY on the back of an improvement in OTC products and oral care portfolio performance. Volume market share of Horlicks (including variants) was 50.4% with value market share of 44.2%. On the other hand, volume market share of Boost was 14.2% with value market share of 11.2% EBITDA increased 38% to | 230.2 crore (I-direct estimate: | 219.5 crore) while EBITDA margins surged 387 bps to 20.8% on the back of 433 bps increase in gross margin, partly offset by higher employee...
More from GlaxoSmithKline Consumer Healthcare Ltd.
Recommended